Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01199328 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate the Interaction Between Aspirin and Nexium
A Phase 1 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT01199328 is a Phase 1 study that has completed, run by AstraZeneca. The registered enrollment target is 34 participants.
The verdict
NCT01199328, a Phase 1 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the interaction between aspirin and Nexium in healthy volunteers.
Interventions
- DRUG Aspirin
- DRUG Esomeprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2010-09 |
| Est. Completion | 2010-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01199328
The ClinicalTrials.gov registry entry for NCT01199328 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aspirin is the first listed.
NCT01199328 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01199328 about?
NCT01199328 is a clinical study titled "Study to Evaluate the Interaction Between Aspirin and Nexium". The purpose of this study is to assess the interaction between aspirin and Nexium in healthy volunteers.
What is the current status of trial NCT01199328?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2010-09. Estimated completion is 2010-11.
What interventions are being tested in trial NCT01199328?
The interventions under investigation include: Aspirin (DRUG), Esomeprazole (DRUG).
Who is sponsoring clinical trial NCT01199328?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.